OS Therapies, a clinical-stage oncology company specializing in gene-edited, Listeria-based cancer immunotherapies, has named Rubenstein Public Relations as its Agency of Record to manage global communications. This partnership comes as OS Therapies advances its lead immunotherapy, OST-HER2, which targets HER2-positive tumors and has received multiple FDA and EMA designations. The company is progressing toward regulatory approvals in the US and UK in 2026, aiming to bring its treatments to market for osteosarcoma and other solid tumors. Rubenstein PR will develop a comprehensive campaign to enhance OS Therapies' corporate messaging and brand presence worldwide.
OS Therapies' recent partnership news is presented alongside Pluang's Health-sector market data as of Oct 08, 2026 19:42 WIB. Of 128 priced Health-sector US stocks tradable on Pluang, 34 rose and 88 fell today. Notable movers include CRSP (Crispr Therapeutics AG) at USD 51.26 with a 1-day change of -2.08% and a typical hold time of 77 days, ABEO (Abeona Therapeutics Inc) at USD 5.18 with a 1-day change of +1.97% and a typical hold time of 24 days, and NVAX (Novavax Inc) at USD 11.00 with a 1-day change of -1.96% and a typical hold time of 59 days.
Third Life World, a developer of a persistent AI-agent world on the Base blockchain, has signed a definitive agreement to acquire voting control of Transglobal Management Group, Inc. (TMGI). This acquisition will make Third Life World's platform the ...
Resilinc introduced a new plugin for Microsoft Copilot that allows authorized enterprise users to access live, organization-specific supply chain risk and compliance intelligence directly within Microsoft applications. This integration helps teams qu...
Le Vian introduces its new Antique Cushion Collection at KAY Jewelers this fall, featuring a patented gemstone cut inspired by vintage old mine diamonds. The collection highlights eight natural gemstones with unique colors and includes 17 in-store st...
AI is transforming the lithium battery value chain by speeding up development, improving manufacturing yields, optimizing resource recovery, and enabling smarter recycling. Significant investments are flowing into AI-driven projects, including $2.2 b...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
